TradingView
AlenCiken
Feb 1, 2019 9:20 PM
significantly improved symptoms of depression
NASDAQ:AXSM
1D
Axsome Therapeutics, Inc.
NASDAQ
Description
⋅
Feb 1, 2019 9:20 PM
significantly improved symptoms of depression in the ASCEND Phase 2 trial in major depressive disorder (MDD)
finance.yahoo.com/news/axsome-therapeutics-announces-axs-05-110000906.html?.tsrc=rss
Trend Analysis
Chart Patterns
Technical Indicators
More